Chmielewska, I.; Krawczyk, P.; Grenda, A.; Wójcik-Superczyńska, M.; Krzyżanowska, N.; Gil, M.; Milanowski, J.
Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience. Cancers 2023, 15, 3732.
https://doi.org/10.3390/cancers15143732
AMA Style
Chmielewska I, Krawczyk P, Grenda A, Wójcik-Superczyńska M, Krzyżanowska N, Gil M, Milanowski J.
Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience. Cancers. 2023; 15(14):3732.
https://doi.org/10.3390/cancers15143732
Chicago/Turabian Style
Chmielewska, Izabela, Paweł Krawczyk, Anna Grenda, Magdalena Wójcik-Superczyńska, Natalia Krzyżanowska, Michał Gil, and Janusz Milanowski.
2023. "Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience" Cancers 15, no. 14: 3732.
https://doi.org/10.3390/cancers15143732
APA Style
Chmielewska, I., Krawczyk, P., Grenda, A., Wójcik-Superczyńska, M., Krzyżanowska, N., Gil, M., & Milanowski, J.
(2023). Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience. Cancers, 15(14), 3732.
https://doi.org/10.3390/cancers15143732
